You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Trump on Cancer-Ridden Biden: ‘I Really Don't Feel Sorry for Him'
- 2. Landscape of targets within nucleoside metabolism for the modification of immune responses
- 3. Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer
- 4. UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer
- 5. ASCO25: Pfizer's Braftovi combo boasts 47% drop in disease progression in mCRC
- 6. Gut bacteria may hold key to unlocking better cancer treatment
- 7. ASCO 2025: Combination of encorafenib and cetuximab with chemotherapy helps some patients with advanced colorectal cancer live longer
- 8. ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer
- 9. Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
- 10. ASCO 2025: Risk of fourteen obesity-related cancers for people with diabetes
Last updated at 20:12 GMT
Hot News Makers
Health/Pharma Companies
-
488119.40
-
111439.37
-
110000.74
-
100743.63
-
83136.47
-
77955.67
-
75197.33
-
45011.45
-
28602.70
-
22154.33
Drugs, Treatments, Trials
-
374891.17
-
36174.94
-
20820.63
-
19639.06
-
9460.01
-
8154.95
-
5096.98
-
5049.23
-
4819.01
-
4699.69
Last updated at 19:10 GMT
